Lifecore Biomedical, Inc. (LFCR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 305.68M |
| Enterprise Value | 430.82M |
| P/E Ratio | -3.37 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 2.07 |
| Price/Book Ratio | -3.28 |
| Enterprise/Revenue | 3.78 |
| Enterprise/EBITDA | -15.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.58 |
| Operating Margin | -0 |
| Return On Assets | -0.3 |
| Return On Equity | 3.82 |
| Revenue | 129.46M |
| Revenue/Share | 3.09 |
| Gross Profit | 40.61M |
| EBITDA | 5.98M |
| Net Income | -30.79M |
| Diluted EPS | -0.92 |
| Total Cash | 23.04M |
| Total Cash/Share | 0.61 |
| Total Debt | 223.16M |
| Total Debt/Equity | -3.04 |
| Current Ratio | 3.84 |
| Book Value Per Share | -0.59 |
| 52-Week Change | -17.7 |
| 52-Week High | 8.98 |
| 52-Week Low | 3.63 |
| Moving Average 50 Days | 5.68 |
| Moving Average 200 Days | 5.44 |
| Average Volume | 407,665 |
| Shares Outstanding | 37.91M |
| % Held by Institutions | 68.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |